Education
About Us
Working with TipRanks
Follow Us
Evotec AG (EVO)
NASDAQ:EVO
See the Price Targets and Ratings of:
EVO Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$8
Buy
139.52%
Upside
Reiterated
11/07/24
Evotec AG's Strategic Growth and Financial Outlook Justifies Buy Rating Amidst Market Challenges
TD Cowen
$10
Buy
199.40%
Upside
Reiterated
11/06/24
Evotec AG: Buy Rating Affirmed Amid Promising Growth Prospects and Strategic Initiatives
Jefferies
$8.7→$3.8
Hold
13.77%
Upside
Downgraded
10/07/24
Evotec downgraded to Hold from Buy at JefferiesEvotec downgraded to Hold from Buy at Jefferies
Bank of America Securities
$4.5→$3
Sell
-10.18%
Downside
Reiterated
08/14/24
Analysts Offer Insights on Healthcare Companies: Evotec AG (NASDAQ: EVO), Medtronic (NYSE: MDT) and Cardinal Health (NYSE: CAH)
Morgan Stanley
$30.23→$12.95
Hold
287.87%
Upside
Downgraded
07/29/24
Evotec downgraded to Equal Weight from Overweight at Morgan StanleyEvotec downgraded to Equal Weight from Overweight at Morgan Stanley
Deutsche Bank
$19
Buy
468.86%
Upside
Upgraded
04/12/24
Deutsche Bank upgrades Evotec (EVO) to BuyDeutsche Bank analyst Falko Friedrichs upgraded Evotec (NASDAQ: EVO) from Hold to Buy.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$8
Buy
139.52%
Upside
Reiterated
11/07/24
Evotec AG's Strategic Growth and Financial Outlook Justifies Buy Rating Amidst Market Challenges
TD Cowen
$10
Buy
199.40%
Upside
Reiterated
11/06/24
Evotec AG: Buy Rating Affirmed Amid Promising Growth Prospects and Strategic Initiatives
Jefferies
$8.7→$3.8
Hold
13.77%
Upside
Downgraded
10/07/24
Evotec downgraded to Hold from Buy at JefferiesEvotec downgraded to Hold from Buy at Jefferies
Bank of America Securities
$4.5→$3
Sell
-10.18%
Downside
Reiterated
08/14/24
Analysts Offer Insights on Healthcare Companies: Evotec AG (NASDAQ: EVO), Medtronic (NYSE: MDT) and Cardinal Health (NYSE: CAH)
Morgan Stanley
$30.23→$12.95
Hold
287.87%
Upside
Downgraded
07/29/24
Evotec downgraded to Equal Weight from Overweight at Morgan StanleyEvotec downgraded to Equal Weight from Overweight at Morgan Stanley
Deutsche Bank
$19
Buy
468.86%
Upside
Upgraded
04/12/24
Deutsche Bank upgrades Evotec (EVO) to BuyDeutsche Bank analyst Falko Friedrichs upgraded Evotec (NASDAQ: EVO) from Hold to Buy.
EVO Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Oct 24
Nov 24
Strong Buy
5
2
1
2
4
Buy
1
1
1
0
0
Hold
0
1
1
2
1
Sell
1
1
1
1
1
Strong Sell
0
0
0
0
0
total
7
5
4
5
6
Each month's total comprises the sum of three months' worth of ratings.
EVO Stock Forecast FAQ
What is EVO’s average 12-month price target, according to analysts?
Based on analyst ratings, Evotec AG’s 12-month average price target is $8.00.
What is EVO’s upside potential, based on the analysts’ average price target?
Evotec AG has 139.52% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is EVO a Buy, Sell or Hold?
Evotec AG has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Evotec AG’s price target?
The average price target for Evotec AG is $8.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $8.00 ,the lowest forecast is $8.00. The average price target represents 139.52% Increase from the current price of $3.34.
The highest analyst price target is $8.00 ,the lowest forecast is $8.00. The average price target represents 139.52% Increase from the current price of $3.34.
What do analysts say about Evotec AG?
Evotec AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of EVO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.